FDA label 9a0f6322-be74-d8f7-e053-2995a90a50ad

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

SPL set ID
cb9e6b7a-98dd-41f3-8e6b-df2321f31977
SPL ID
9a0f6322-be74-d8f7-e053-2995a90a50ad
Version
2
Effective date
2019-12-19
Source export date
2026-09-28
Source partition
8
Source file
https://download.open.fda.gov/drug/label/drug-label-0008-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-09-28/ae3816359e336a5de4f44607730a3d12ceb61ffa012a132189ceda22541b38ee/drug-label-0008-of-0014.json.zip
Source manifest SHA-256
cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run
20260929T050834Z
Imported at
2026-09-29 05:51:55

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings •For external use only Do not use •if you have sensitive skin or are sensitive to benzoyl peroxide When using this product •avoid contact with eyes, lips and mouth •avoid contact with hair or dyed fabrics including carpet and clothing which may be bleached by this product •with other topical acne medicaitons, at the same time nor immediately following use of this product, increased dryness or irritation of the skin may occur. If this occurs, only one medicaiton should be used unless directed by a doctor •skin irritaiton may occur, characterized by redness, burning, itching, peeling or possibly swelling. More frequent use or higher concentration may aggravtae skin irritation. Mild irritation may be reduced by using the product less frequently or in a lower concentration •avoid unnecessary sun exposure and use a sunscreen Stop use and ask a doctor •if skin irritation becomes severe

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.